Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Safety and effectiveness"'
Publikováno v:
Zhongguo yiliao qixie zazhi, Vol 48, Iss 1, Pp 80-84 (2024)
Through the effective application of Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices (EP), to continuously improve the corresponding management tools to ensure the safety and effectiveness of medical device i
Externí odkaz:
https://doaj.org/article/f9d690aef72748b1af04cd02c85b9df2
Publikováno v:
Українська Інтервенційна Нейрорадіологія та Хірургія, Vol 45, Iss 3, Pp 27-46 (2023)
Objective ‒ to perform the analysis and biophysical substantiation of a new technique of catheter radiofrequency ablation (RFA) with high power and short duration based on mathematical modeling of own clinical data of the electro-thermodynamic effe
Externí odkaz:
https://doaj.org/article/2633dd4027404ddb97b09f299f465647
Autor:
Mitzi J. Williams, Lilyana Amezcua, Angel Chinea, Stanley Cohan, Annette Okai, Darin T. Okuda, Wendy Vargas, Nick Belviso, Ivan Božin, Xiaotong Jiang, James B. Lewin, Jennifer Lyons, Changyu Shen, Sarah M. England, Nydjie Grimes
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1669-1682 (2023)
Abstract Introduction Multiple sclerosis (MS) clinical trials have included low numbers of patients from racial and ethnic minority populations; therefore, it is uncertain whether differences exist in response to disease-modifying therapies. We evalu
Externí odkaz:
https://doaj.org/article/2c2b0b4ff387415eaeb5b39904d4d74c
Autor:
Mohammed M. Alsultan, Abdullah K. Alahmari, Mansour A. Mahmoud, Ziyad S. Almalki, Wafa Alzlaiq, Faisal Alqarni, Fahad Alsultan, Nehad Jaser Ahmed, Ahmed O. Alenazi, Lucas Scharf, Jeff Jianfei Guo
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia type. Patients with AF are often administered anticoagulants to reduce the risk of ischemic stroke due to an irregular heartbeat. We evaluated the efficacy and safety of ed
Externí odkaz:
https://doaj.org/article/7538e14af63e4347959d9490c269a33b
Autor:
Chaofeng Chen, Kuan Cheng, Xiaofei Gao, Tian Zou, Yang Pang, Yunlong Ling, Ye Xu, Yizhou Xu, Qingxing Chen, Wenqing Zhu, Junbo Ge
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 518-531 (2023)
Abstract Aims Limited data are available on the outcomes of cryoballoon ablation (CBA)‐based pulmonary vein isolation (PVI) for atrial fibrillation (AF) in patients with heart failure (HF) with preserved ejection fraction (HFpEF) and mildly reduced
Externí odkaz:
https://doaj.org/article/e26fa042b94d4d10b25ff012ac5723fa
Autor:
Bin Zhang, Mengna Zhang, Ying'an Zhao, Xuanlei Ren, Jianbo Zheng, Jiyun Zhu, Jianshuai Jiang, Siming Zheng
Publikováno v:
Intelligent Surgery, Vol 6, Iss , Pp 16-20 (2023)
Objective: To report a case of da Vinci robotic-assisted radical resection of hilar cholangiocarcinoma. This case is shared to discuss the techniques, methods and ideas for the treatment of hilar cholangiocarcinoma. Methods: The patient was diagnosed
Externí odkaz:
https://doaj.org/article/94634e8402974898942bebc88659fa09
Autor:
Ge Xiong, Richard Benjamin Young, Helen Chow, Emanual Maverakis, Ricardo A. Maselli, David Paul Richman, Tianhong Li
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Immune checkpoint inhibitors cause rare but potentially fatal neuromuscular complications, leading to a concern to use these agents in cancer patients with pre-existing autoimmune or inflammatory neuromuscular diseases. We report two such patients wi
Externí odkaz:
https://doaj.org/article/a32a96c7cd7d4a50bb4c9b041a1cac72
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
Publikováno v:
Intestinal Research, Vol 20, Iss 3, Pp 329-341 (2022)
Background/Aims Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiated to evaluate its safety and effectiveness in pa
Externí odkaz:
https://doaj.org/article/71e114b21acf4f648efaa0b86a6ec480
Publikováno v:
Heliyon, Vol 9, Iss 4, Pp e15490- (2023)
Background: Xihuang pill, a Traditional Chinese Medicine (TCM) prescription and a representative of Huoxuehuayu therapy (one of the TCM therapies to promote blood circulation and remove blood stasis), has been widely used in breast cancer treatments.
Externí odkaz:
https://doaj.org/article/a11b12a44cc840ce8015de058eb69a83